Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study

Purpose: Due to the excellent outcomes with image-guided stereotactic body radiotherapy for patients with early-stage non–small cell lung cancer (NSCLC) and the low treatment-related toxicities using proton therapy (PT), we investigated treatment outcomes and toxicities when delivering hypofractiona...

Full description

Bibliographic Details
Main Authors: Shivam M. Kharod, MD, R.Charles Nichols, MD, Randal H. Henderson, MD, MBA, Christopher G. Morris, MS, Dat C. Pham, MD, Vandana K. Seeram, MBBS, Lisa M. Jones, MD, Maria Antonio-Miranda, MD, Daniel A. Siragusa, MD, Zuofeng Li, DSc, Stella Flampouri, PhD, MSc, Bradford S. Hoppe, MD, MPH
Format: Article
Language:English
Published: Particle Therapy Co-operative Group 2020-11-01
Series:International Journal of Particle Therapy
Subjects:
radiation therapy
outcomes
toxicity
hypofractionated adiotherapy
adverse events
Online Access:https://theijpt.org/doi/pdf/10.14338/IJPT-20-00013.1

Internet

https://theijpt.org/doi/pdf/10.14338/IJPT-20-00013.1

Similar Items